Publication | Closed Access

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Androgen-deprivation TherapyUrologyGenitourinary CancerMedicineCancer ManagementProstatic DiseaseOncologyRadiation OncologyEndocrine-related CancerTrog 03.06